Aesch, Switzerland
Pentapharm, established in 1948 and headquartered in Switzerland, is a pioneering entity in the realms of Health Care, Health and Wellness, Medical Devices, and Pharmaceuticals. With a storied history beginning as a research and development firm under the guidance of founder Viktor Stürm, the company specializes in transforming naturally occurring raw materials into advanced medical solutions.
Renowned for its unique capability in producing coagulation diagnostics reagent kits and active pharmaceutical ingredients, Pentapharm has established itself as a key supplier within the diagnostic industry. Its innovative products—ranging from snake venom enzymes to coagulation factor substrates—anchor its reputation in hemostasis and thrombotic risk assessment.
As a wholly owned subsidiary of dsm-firmenich since 2007, the company remains a partner of choice for those seeking OEM assays or diagnostic kits. Investors should note that no recent investments have been recorded, highlighting potential opportunities for future engagement.
